Streetbeat News

Earnings

KAVL

Kaival Brands Innovations reported its Q1 2024 earnings with an EPS of $(0.76), an improvement from $(1.12) year-over-year. Revenue increased to $3.2M from $2.5M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:33 pm

DRCT

IBIO

NVCR

IBio shares surged 119% following a collaboration with AstralBio on AI-driven antibodies for obesity and cardiometabolic diseases. Direct Digital Holdings' shares plummeted by 49% due to disappointing Q4 financial results. Novocure's stock rose 42% after its METIS Phase 3 trial for brain metastases from non-small cell lung cancer met its primary endpoint.

Portfolio Pulse from ryanfaloona@benzinga.com

March 27, 2024 | 12:31 pm

ACN

AZO

SCS

WDAY

Insiders at Workday, AutoZone, Accenture, and Steelcase have recently sold shares, indicating potential concerns or views of overvaluation. Workday's insider sold shares after announcing financial results and an acquisition. AutoZone's sale followed an analyst's price target increase. Accenture's COO sold shares after mixed quarterly results, and Steelcase's COO sold shares following mixed financial results and weak revenue guidance.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 12:24 pm

SIDU

Sidus Space reported a FY23 EPS of $(23.11), an improvement from $(74.80) YoY, with revenue decreasing to $5.96M from $7.29M YoY. The company saw a 26% decrease in cost of revenue and a 14% increase in gross profit, driven by higher margin satellite business. SG&A expenses rose due to legal costs and acquisition expenses, leading to a net loss of $14.3M. Cash decreased to $1.2M, with a subsequent increase in funds through warrant exercises and offerings. Liabilities increased across accounts payable, asset-based loan liability, and notes payable.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:15 pm

MRDB

PRGS

MariaDB plc (MRDB) shares surged by approximately 100% in pre-market trading following an announcement by Progress Software (PRGS) about a potential offer for the company. Other stocks also showed significant movement in pre-market trading, with notable gainers including Destiny Tech100 Inc (DXYZ), PaySign, Inc. (PAYS), and Hitek Global Inc. (HKIT), among others. On the losing end, Direct Digital Holdings, Inc. (DRCT), Velo3D, Inc. (VLD), and JOANN Inc. (JOAN) experienced substantial declines after reporting disappointing financial results or facing delisting issues.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 12:14 pm

COST

CVS

TGT

On CNBC's 'Halftime Report Final Trades,' CVS Health Corporation (CVS) was highlighted for its strong comeback amid Amazon Pharmacy's expansion. Costco (COST) was favored despite missing revenue estimates, showing a 5.7% year-over-year sales increase. Target (TGT) was recommended after reporting a revenue growth of 1.7% year-on-year, despite a decline in comparable sales. CVS reaffirmed its 2024 earnings guidance, while Amazon launched Same-Day Delivery in select areas.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 12:14 pm

AEZS

AEterna Zentaris reported Q4 2023 GAAP EPS of $(1.16), missing the $(0.97) estimate, with sales of $100K, a 95.98% decrease from $2.485M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:10 pm

UNF

UniFirst projects its FY24 revenue to be between $2.415B and $2.425B, closely aligning with the estimated $2.42B. The company also forecasts its EPS to range from $6.80 to $7.16, which brackets the estimated $6.90.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:08 pm

ALGS

Aligos Therapeutics, Inc. (NASDAQ:ALGS) announced its participation in the 33rd Annual Meeting of the APASL 2024 with presentations on ALG-055009 and ALG-000184 Phase 1 studies. ALG-055009 showed favorable effects in hyperlipidemic subjects, while ALG-000184 demonstrated potent antiviral activity in CHB patients. The company remains optimistic about the potential of these compounds in treating liver and viral diseases.

Portfolio Pulse from Happy Mohamed

March 27, 2024 | 12:07 pm

UNF

UniFirst (NYSE:UNF) reported Q2 earnings of $1.09 per share, missing the consensus estimate of $1.23 by 11.38%, but showed a 14.74% increase from last year. Sales reached $590.70M, slightly above the $587.84M estimate, marking an 8.85% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:06 pm